Evidence map›Paper›PMID 20418359›Full record

ArticleRNA (New York, N.Y.)2010

A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control.

Edward Hitti, Suhad Al-Yahya, Maher Al-Saif, Peer Mohideen, Linah Mahmoud, Stephen J Polyak, Khalid S A Khabar

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. UU/UA dinucleotide frequency reduction in coding regions results in increased mRNA stability and protein expression.Molecular therapy : the journal of the American Society of Gene Therapy · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Edward HittiProgram in BioMolecular Research, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia 11211.
Suhad Al-Yahya
Maher Al-Saif
Peer Mohideen
Linah Mahmoud
Stephen J Polyak
Khalid S A Khabar
Alfaisal University · SAKing Faisal Specialist Hospital & Research Centre · SAUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Assessment of post-transcriptional control relies on use of transcriptional inhibitors and is masked by copious and cryptic transcriptional induction. We screened several cellular promoters that are constitutively active yet noninducible to external stimuli. The ribosomal protein RPS30 promoter was chosen; its TATA signal and sp1 site location were optimized. The modified promoter (RPS30M) is selective to post-transcriptional effects of AU-rich elements (ARE) in the 3'UTR, while it is not transcriptionally responsive to a wide variety of agents including pro-inflammatory cytokines and RNA-binding proteins. Specific cis-acting elements can be appended to RPS30M by a cloning-free approach to allow coupled transcriptional/post-transcriptional assessment, as demonstrated with NF-kappaB and beta-catenin/wnt signaling experiments. Moreover, efficient tetracycline-regulated RPS30M was created for quantitative assessment of the half-lives of mRNAs containing AREs. The described approach provides enhanced versatility and suitability for selective post-transcriptional assessment with or without transcriptional induction.

Indexed as

RNA Processing, Post-TranscriptionalTranscription, Genetic3' Untranslated RegionsCloning, MolecularGene Expression RegulationHumansNF-kappa BPromoter Regions, GeneticRibosomal ProteinsRNA, MessengerRNA StabilitySignal Transduction3' Untranslated RegionsFAU protein, humanNF-kappa BRibosomal ProteinsRNA, Messenger

Identifiers

PMID20418359
PMCPMC2874176
OpenAlexW2116296367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.